Curium Pharma recently disclosed that it suffered a data breach that compromised the sensitive personal data of certain individuals.
What Happened?
Curium Pharma, a global leader in nuclear medicine, confirmed a data breach involving unauthorized access to sensitive personal and clinical trial data. The breach occurred between October 15 and October 19, 2024, with the incident first detected on October 17, 2024. An internal investigation determined that the compromised information included Social Security numbers, medical records, prescription information, and other personal identifiers for affected individuals. Curium began mailing breach notification letters around June 20–25, 2025.
About Curium Pharma
Curium Pharma specializes in diagnostic and therapeutic radiopharmaceuticals and is committed to innovation and patient safety.
Was Your Information Impacted by the Breach?
If you received a notice from Curium Pharma, your confidential information may be at risk for misuse or identity theft.
Are You Entitled to Compensation?
Siri & Glimstad LLP is investigating whether Curium failed to adequately protect your information under applicable privacy and security laws.
What Should You Do Next?
If you received a data breach letter from Curium Pharma, contact Siri & Glimstad, a nationally recognized and trusted data privacy law firm that has recovered tens of millions of dollars for consumers. The firm’s team of over 60 attorneys and other legal professionals has a winning track record in the data privacy space, holding companies accountable for lax data privacy practices, and securing compensation for millions of consumers.